Figures & data
Table 1. Demographic data summary.
Table 2. Summary of the countries that participated in the international part of the study.
Figure 1. Q1: Do you accept pharmacists to take part in campaigns for increasing population’s awareness concerning the administration of the compulsory immunizations and reimmunizations as per the immunization calendar of your country?
![Figure 1. Q1: Do you accept pharmacists to take part in campaigns for increasing population’s awareness concerning the administration of the compulsory immunizations and reimmunizations as per the immunization calendar of your country?](/cms/asset/68a83ef7-e077-4916-acda-5f35349238a3/tbeq_a_2252106_f0001_c.jpg)
Figure 5. Q5: Are you familiar with the fact that vaccines against COVID-19 have received conditional marketing authorization on the territory of EU for a period of 1 (one) year?
![Figure 5. Q5: Are you familiar with the fact that vaccines against COVID-19 have received conditional marketing authorization on the territory of EU for a period of 1 (one) year?](/cms/asset/f317d01a-2df1-48fe-81d5-920fdf602ba7/tbeq_a_2252106_f0005_c.jpg)
Figure 7. Q12: Would you recommend vaccination to your patients more confidently if vaccines have marketing authorization valid for 5 (five) years?
![Figure 7. Q12: Would you recommend vaccination to your patients more confidently if vaccines have marketing authorization valid for 5 (five) years?](/cms/asset/2cfa9bbb-05f5-4035-8ef0-0a1c9db167fa/tbeq_a_2252106_f0007_c.jpg)
Figure 8. Q11: Do you consider yourself familiar enough with the most frequent ADRs (adverse drug reactions) after administration of a COVID-19 vaccine?
![Figure 8. Q11: Do you consider yourself familiar enough with the most frequent ADRs (adverse drug reactions) after administration of a COVID-19 vaccine?](/cms/asset/ae63175e-1500-4b15-ae81-9ceee1f513e6/tbeq_a_2252106_f0008_c.jpg)
Figure 9. Q16: Do you agree with the statement that the vaccines authorized for use in EU are ‘of high quality, efficacious and safe’?
![Figure 9. Q16: Do you agree with the statement that the vaccines authorized for use in EU are ‘of high quality, efficacious and safe’?](/cms/asset/9e384647-4b89-41d3-9669-4eeff1d49a53/tbeq_a_2252106_f0009_c.jpg)
Data availability statement
The data that support the findings reported in this study are available from the corresponding author [MD] upon reasonable request.